Evox Therapeutics reaches gene therapy agreement
Partnership with Icahn School of Medicine will involve developing exoAAV vectors for heart disease patients
Read More
Tag: Evox
Lilly signs up for access to Evox’ tech in R&D deal
Evox’ technology modifies exosomes to deliver drugs to areas currently inaccessible
Read More
Takeda, Evox link up to the tune of $882m
Evox will offer its preclinical programme in Niemann-Pick disease type C for development, and a second new programme directed at another undisclosed rare disease.
Read More
Evox bags grant from Duchenne UK to engineer exosomes
Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.
Read More
Evox raises £35m for exosome therapeutics
Oxford, UK-based Evox Therapeutics has raised £35 million to help advance its exosome-based therapeutics pipeline.
Read More
Boehringer Ingelheim signs Evox, Roche deals
Boehringer Ingelheim signs new deals with UK-based Evox Technologies and Roche.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
